{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,10]],"date-time":"2026-04-10T05:48:54Z","timestamp":1775800134221,"version":"3.50.1"},"reference-count":40,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,4,9]]},"DOI":"10.7759\/cureus.106752","type":"journal-article","created":{"date-parts":[[2026,4,10]],"date-time":"2026-04-10T04:52:34Z","timestamp":1775796754000},"source":"Crossref","is-referenced-by-count":0,"title":["Blood Transfusion Practices in Rural Hospitals: Indications, Challenges, and Practical Solutions"],"prefix":"10.7759","author":[{"given":"Vijay Ramesh","family":"Topno","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ghanshyam","family":"Bihari","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gaurav","family":"Mishra","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dharmendra","family":"Kumar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.5334\/aogh.2426","article-title":"Assessment of blood donation and transfusion in Eastern Uganda: a mixed-methods study","volume":"85","author":"Checkley L","year":"2019","unstructured":"Checkley L, Motwani G, Wange IC, et al.. Assessment of blood donation and transfusion in Eastern Uganda: a mixed-methods study. Ann Glob Health. 2019, 85:59. 10.5334\/aogh.2426","journal-title":"Ann Glob Health"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1186\/s12885-024-13216-3","article-title":"Incidence and risk factor of blood transfusion after abdominal radical hysterectomy for cervical cancer: a 10-year retrospective study of the US nationwide inpatient sample","volume":"24","author":"Chen C","year":"2024","unstructured":"Chen C, Zhu B, Wang Y, et al.. Incidence and risk factor of blood transfusion after abdominal radical hysterectomy for cervical cancer: a 10-year retrospective study of the US nationwide inpatient sample. BMC Cancer. 2024, 24:1454. 10.1186\/s12885-024-13216-3","journal-title":"BMC Cancer"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.4269\/ajtmh.20-0601","article-title":"Distribution and incidence of blood-borne infection among blood donors from regional transfusion centers in Burkina Faso: a comprehensive study","volume":"104","author":"Wongjarupong N","year":"2021","unstructured":"Wongjarupong N, Oli S, Sanou M, et al.. Distribution and incidence of blood-borne infection among blood donors from regional transfusion centers in Burkina Faso: a comprehensive study. Am J Trop Med Hyg. 2021, 104:1577-1581. 10.4269\/ajtmh.20-0601","journal-title":"Am J Trop Med Hyg"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0168401","article-title":"Transfusion: -80\u00b0C frozen blood products are safe and effective in military casualty care","volume":"11","author":"Noorman F","year":"2016","unstructured":"Noorman F, van Dongen TT, Plat MJ, Badloe JF, Hess JR, Hoencamp R. Transfusion: -80\u00b0C frozen blood products are safe and effective in military casualty care. PLoS One. 2016, 11:e0168401. 10.1371\/journal.pone.0168401","journal-title":"PLoS One"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1007\/s00068-022-02050-6","article-title":"Resuscitation with whole blood or blood components improves survival and lessens the pathophysiological burden of trauma and haemorrhagic shock in a pre-clinical porcine model","volume":"49","author":"Watts SA","year":"2023","unstructured":"Watts SA, Smith JE, Woolley T, Rickard RF, Gwyther R, Kirkman E. Resuscitation with whole blood or blood components improves survival and lessens the pathophysiological burden of trauma and haemorrhagic shock in a pre-clinical porcine model. Eur J Trauma Emerg Surg. 2023, 49:227-239. 10.1007\/s00068-022-02050-6","journal-title":"Eur J Trauma Emerg Surg"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1159\/000519676","article-title":"Prehospital whole blood transfusion programs in Norway","volume":"48","author":"Bjerkvig CK","year":"2021","unstructured":"Bjerkvig CK, Strandenes G, Hervig T, Sunde GA, Apelseth TO. Prehospital whole blood transfusion programs in Norway. Transfus Med Hemother. 2021, 48:324-331. 10.1159\/000519676","journal-title":"Transfus Med Hemother"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.4102\/safp.v66i1.5958","article-title":"A clinical audit of red blood cell transfusion practices at a district hospital in South Africa","volume":"66","author":"Madito NS","year":"2024","unstructured":"Madito NS, Van Rooyen C, Hagemeister DT. A clinical audit of red blood cell transfusion practices at a district hospital in South Africa. S Afr Fam Pract. 2024, 66:e1-e8. 10.4102\/safp.v66i1.5958","journal-title":"S Afr Fam Pract"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.4103\/apjon.apjon_50_20","article-title":"Bedside blood transfusion - what nurses know and perform: a cross-sectional study from a tertiary-level cancer hospital in rural Kerala","volume":"8","author":"Jogi IE","year":"2021","unstructured":"Jogi IE, Mohanan N, Nedungalaparambil NM. Bedside blood transfusion - what nurses know and perform: a cross-sectional study from a tertiary-level cancer hospital in rural Kerala. Asia Pac J Oncol Nurs. 2021, 8:197-203. 10.4103\/apjon.apjon_50_20","journal-title":"Asia Pac J Oncol Nurs"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1186\/s12879-024-09119-0","article-title":"Trends in immunological markers of transfusion transmissible infections among blood donors in Mamfe District Hospital, Southwest Cameroon","volume":"24","author":"Ngomtcho SC","year":"2024","unstructured":"Ngomtcho SC, Njike Ngo Biyong O, Ekwere TA, et al.. Trends in immunological markers of transfusion transmissible infections among blood donors in Mamfe District Hospital, Southwest Cameroon. BMC Infect Dis. 2024, 24:370. 10.1186\/s12879-024-09119-0","journal-title":"BMC Infect Dis"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.2147\/JBM.S310329","article-title":"Human immunodeficiency virus and syphilis among blood donors at Western Oromia, Ethiopia","volume":"12","author":"Abebe M","year":"2021","unstructured":"Abebe M, Marga N. Human immunodeficiency virus and syphilis among blood donors at Western Oromia, Ethiopia. J Blood Med. 2021, 12:671-677. 10.2147\/JBM.S310329","journal-title":"J Blood Med"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.18295\/squmj.2018.18.01.002","article-title":"Transfusion in haemoglobinopathies: review and recommendations for local blood banks and transfusion services in Oman","volume":"18","author":"Al-Riyami AZ","year":"2018","unstructured":"Al-Riyami AZ, Daar S. Transfusion in haemoglobinopathies: review and recommendations for local blood banks and transfusion services in Oman. Sultan Qaboos Univ Med J. 2018, 18:e3-e12. 10.18295\/squmj.2018.18.01.002","journal-title":"Sultan Qaboos Univ Med J"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2020248","article-title":"Higher or lower hemoglobin transfusion thresholds for preterm infants","volume":"383","author":"Kirpalani H","year":"2020","unstructured":"Kirpalani H, Bell EF, Hintz SR, et al.. Higher or lower hemoglobin transfusion thresholds for preterm infants. N Engl J Med. 2020, 383:2639-2651. 10.1056\/NEJMoa2020248","journal-title":"N Engl J Med"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1016\/j.tmrv.2018.07.003","article-title":"Impact of red blood cell antigen matching on alloimmunization and transfusion complications in patients with sickle cell disease: a systematic review","volume":"33","author":"Fasano RM","year":"2019","unstructured":"Fasano RM, Meyer EK, Branscomb J, White MS, Gibson RW, Eckman JR. Impact of red blood cell antigen matching on alloimmunization and transfusion complications in patients with sickle cell disease: a systematic review. Transfus Med Rev. 2019, 33:12-23. 10.1016\/j.tmrv.2018.07.003","journal-title":"Transfus Med Rev"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1007\/s11739-025-03889-4","article-title":"Optimal hemoglobin threshold for blood transfusions in sepsis and septic shock: a retrospective analysis","volume":"20","author":"Permpikul C","year":"2025","unstructured":"Permpikul C, Tanksinmankhong J, Tongyoo S, Naorungroj T, Viarasilpa T, Karaketklang K. Optimal hemoglobin threshold for blood transfusions in sepsis and septic shock: a retrospective analysis. Intern Emerg Med. 2025, 20:829-839. 10.1007\/s11739-025-03889-4","journal-title":"Intern Emerg Med"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1128\/mbio.03287-22","article-title":"Endemic human coronavirus antibody levels are unchanged after convalescent or control plasma transfusion for early outpatient COVID-19 treatment","volume":"14","author":"Karaba AH","year":"2023","unstructured":"Karaba AH, Johnston TS, Beck E, Laeyendecker O, Cox AL, Klein SL, Sullivan DJ. Endemic human coronavirus antibody levels are unchanged after convalescent or control plasma transfusion for early outpatient COVID-19 treatment. mBio. 2023, 14:e0328722. 10.1128\/mbio.03287-22","journal-title":"mBio"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1097\/TA.0000000000003251","article-title":"Dose-dependent association between blood transfusion and nosocomial infections in trauma patients: a secondary analysis of patients from the PAMPer trial","volume":"91","author":"Ladhani HA","year":"2021","unstructured":"Ladhani HA, Ho VP, Charbonnet CC, et al.. Dose-dependent association between blood transfusion and nosocomial infections in trauma patients: a secondary analysis of patients from the PAMPer trial. J Trauma Acute Care Surg. 2021, 91:272-278. 10.1097\/TA.0000000000003251","journal-title":"J Trauma Acute Care Surg"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1097\/TA.0000000000002903","article-title":"Group A emergency-release plasma in trauma patients requiring massive transfusion","volume":"89","author":"de Roulet A","year":"2020","unstructured":"de Roulet A, Kerby JD, Weinberg JA, et al.. Group A emergency-release plasma in trauma patients requiring massive transfusion. J Trauma Acute Care Surg. 2020, 89:1061-1067. 10.1097\/TA.0000000000002903","journal-title":"J Trauma Acute Care Surg"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1097\/TA.0000000000003551","article-title":"Prehospital low titer group O whole blood is feasible and safe: results of a prospective randomized pilot trial","volume":"92","author":"Guyette FX","year":"2022","unstructured":"Guyette FX, Zenati M, Triulzi DJ, et al.. Prehospital low titer group O whole blood is feasible and safe: results of a prospective randomized pilot trial. J Trauma Acute Care Surg. 2022, 92:839-847. 10.1097\/TA.0000000000003551","journal-title":"J Trauma Acute Care Surg"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.3324\/haematol.2017.184788","article-title":"Plerixafor enables safe, rapid, efficient mobilization of hematopoietic stem cells in sickle cell disease patients after exchange transfusion","volume":"103","author":"Lagresle-Peyrou C","year":"2018","unstructured":"Lagresle-Peyrou C, Lefr\u00e8re F, Magrin E, et al.. Plerixafor enables safe, rapid, efficient mobilization of hematopoietic stem cells in sickle cell disease patients after exchange transfusion. Haematologica. 2018, 103:778-786. 10.3324\/haematol.2017.184788","journal-title":"Haematologica"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.2450\/2016.0184-15","article-title":"Recommendations for the electronic pre-transfusion check at the bedside","volume":"14","author":"Ohsaka A","year":"2016","unstructured":"Ohsaka A, Kato H, Kino S, et al.. Recommendations for the electronic pre-transfusion check at the bedside. Blood Transfus. 2016, 14:419-424. 10.2450\/2016.0184-15","journal-title":"Blood Transfus"},{"key":"ref21","doi-asserted-by":"publisher","DOI":"10.1007\/s00134-020-06266-1","article-title":"Viscoelastic haemostatic assay augmented protocols for major trauma haemorrhage (ITACTIC): a randomized, controlled trial","volume":"47","author":"Baksaas-Aasen K","year":"2021","unstructured":"Baksaas-Aasen K, Gall LS, Stensballe J, et al.. Viscoelastic haemostatic assay augmented protocols for major trauma haemorrhage (ITACTIC): a randomized, controlled trial. Intensive Care Med. 2021, 47:49-59. 10.1007\/s00134-020-06266-1","journal-title":"Intensive Care Med"},{"key":"ref22","doi-asserted-by":"publisher","DOI":"10.1186\/s13063-017-2224-9","article-title":"iTACTIC - implementing Treatment Algorithms for the Correction of Trauma-Induced Coagulopathy: study protocol for a multicentre, randomised controlled trial","volume":"18","author":"Baksaas-Aasen K","year":"2017","unstructured":"Baksaas-Aasen K, Gall L, Eaglestone S, et al.. iTACTIC - implementing Treatment Algorithms for the Correction of Trauma-Induced Coagulopathy: study protocol for a multicentre, randomised controlled trial. Trials. 2017, 18:486. 10.1186\/s13063-017-2224-9","journal-title":"Trials"},{"key":"ref23","doi-asserted-by":"publisher","DOI":"10.1016\/j.burns.2020.06.038","article-title":"The best strategy for red blood cell transfusion in severe burn patients, restrictive or liberal: a randomized controlled trial","volume":"47","author":"Salehi SH","year":"2021","unstructured":"Salehi SH, Daniali M, Motaghi P, Momeni M. The best strategy for red blood cell transfusion in severe burn patients, restrictive or liberal: a randomized controlled trial. Burns. 2021, 47:1038-1044. 10.1016\/j.burns.2020.06.038","journal-title":"Burns"},{"key":"ref24","doi-asserted-by":"publisher","DOI":"10.1007\/s00068-025-02848-0","article-title":"Pragmatic O-Positive Whole-blood RandoMizaTion in male trauma Patients (POWeR-MTP)","volume":"51","author":"Strada AM","year":"2025","unstructured":"Strada AM, Suarez G, Luo-Owen X, et al.. Pragmatic O-Positive Whole-blood RandoMizaTion in male trauma Patients (POWeR-MTP). Eur J Trauma Emerg Surg. 2025, 51:175. 10.1007\/s00068-025-02848-0","journal-title":"Eur J Trauma Emerg Surg"},{"key":"ref25","doi-asserted-by":"publisher","DOI":"10.1177\/03000605231206963","article-title":"Application of an autotransfusion pressure control system in blood salvage","volume":"51","author":"Wu Y","year":"2023","unstructured":"Wu Y, He J, Han X, Xu Q, Dai H, Wu J. Application of an autotransfusion pressure control system in blood salvage. J Int Med Res. 2023, 51:3000605231206963. 10.1177\/03000605231206963","journal-title":"J Int Med Res"},{"key":"ref26","doi-asserted-by":"publisher","DOI":"10.1097\/MD.0000000000036407","article-title":"The efficacy of temperature intervention combined with tranexamic acid in reducing blood loss and accelerating recovery during spinal fusion","volume":"102","author":"Li F","year":"2023","unstructured":"Li F, Huang X, Huang Y, Liang B, Yin D. The efficacy of temperature intervention combined with tranexamic acid in reducing blood loss and accelerating recovery during spinal fusion. Medicine (Baltimore). 2023, 102:e36407. 10.1097\/MD.0000000000036407","journal-title":"Medicine (Baltimore)"},{"key":"ref27","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2017.73.4418","article-title":"SIMPLIFY-1: a phase III randomized trial of momelotinib versus ruxolitinib in Janus kinase inhibitor-na\u00efve patients with myelofibrosis","volume":"35","author":"Mesa RA","year":"2017","unstructured":"Mesa RA, Kiladjian JJ, Catalano JV, et al.. SIMPLIFY-1: a phase III randomized trial of momelotinib versus ruxolitinib in Janus kinase inhibitor-na\u00efve patients with myelofibrosis. J Clin Oncol. 2017, 35:3844-3850. 10.1200\/JCO.2017.73.4418","journal-title":"J Clin Oncol"},{"key":"ref28","doi-asserted-by":"publisher","DOI":"10.3324\/haematol.2014.115840","article-title":"Efficacy, safety, and survival with ruxolitinib in patients with myelofibrosis: results of a median 3-year follow-up of COMFORT-I","volume":"100","author":"Verstovsek S","year":"2015","unstructured":"Verstovsek S, Mesa RA, Gotlib J, et al.. Efficacy, safety, and survival with ruxolitinib in patients with myelofibrosis: results of a median 3-year follow-up of COMFORT-I. Haematologica. 2015, 100:479-488. 10.3324\/haematol.2014.115840","journal-title":"Haematologica"},{"key":"ref29","doi-asserted-by":"publisher","DOI":"10.1186\/s12871-023-02317-4","article-title":"Metabolomics and machine learning approaches for diagnostic and prognostic biomarkers screening in sepsis","volume":"23","author":"She H","year":"2023","unstructured":"She H, Du Y, Du Y, et al.. Metabolomics and machine learning approaches for diagnostic and prognostic biomarkers screening in sepsis. BMC Anesthesiol. 2023, 23:367. 10.1186\/s12871-023-02317-4","journal-title":"BMC Anesthesiol"},{"key":"ref30","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1803537","article-title":"Plasma exchange and glucocorticoids in severe ANCA-associated vasculitis","volume":"382","author":"Walsh M","year":"2020","unstructured":"Walsh M, Merkel PA, Peh CA, et al.. Plasma exchange and glucocorticoids in severe ANCA-associated vasculitis. N Engl J Med. 2020, 382:622-631. 10.1056\/NEJMoa1803537","journal-title":"N Engl J Med"},{"key":"ref31","doi-asserted-by":"publisher","DOI":"10.1161\/JAHA.120.021765","article-title":"Thromboprophylaxis for children post-Fontan procedure: insights from the UNIVERSE study","volume":"10","author":"McCrindle BW","year":"2021","unstructured":"McCrindle BW, Michelson AD, Van Bergen AH, et al.. Thromboprophylaxis for children post-Fontan procedure: insights from the UNIVERSE study. J Am Heart Assoc. 2021, 10:e021765. 10.1161\/JAHA.120.021765","journal-title":"J Am Heart Assoc"},{"key":"ref32","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2212111","article-title":"Azithromycin to prevent sepsis or death in women planning a vaginal birth","volume":"388","author":"Tita AT","year":"2023","unstructured":"Tita AT, Carlo WA, McClure EM, et al.. Azithromycin to prevent sepsis or death in women planning a vaginal birth. N Engl J Med. 2023, 388:1161-1170. 10.1056\/NEJMoa2212111","journal-title":"N Engl J Med"},{"key":"ref33","doi-asserted-by":"publisher","DOI":"10.1007\/s00134-025-07910-4","article-title":"Efficacy of targeting high mean arterial pressure for older patients with septic shock (OPTPRESS): a multicentre, pragmatic, open-label, randomised controlled trial","volume":"51","author":"Endo A","year":"2025","unstructured":"Endo A, Yamakawa K, Tagami T, et al.. Efficacy of targeting high mean arterial pressure for older patients with septic shock (OPTPRESS): a multicentre, pragmatic, open-label, randomised controlled trial. Intensive Care Med. 2025, 51:883-892. 10.1007\/s00134-025-07910-4","journal-title":"Intensive Care Med"},{"key":"ref34","doi-asserted-by":"publisher","DOI":"10.1164\/rccm.202004-1201OC","article-title":"Procalcitonin to reduce long-term infection-associated adverse events in sepsis. A randomized trial","volume":"203","author":"Kyriazopoulou E","year":"2021","unstructured":"Kyriazopoulou E, Liaskou-Antoniou L, Adamis G, et al.. Procalcitonin to reduce long-term infection-associated adverse events in sepsis. A randomized trial. Am J Respir Crit Care Med. 2021, 203:202-210. 10.1164\/rccm.202004-1201OC","journal-title":"Am J Respir Crit Care Med"},{"key":"ref35","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1907423","article-title":"A randomized trial of erythropoietin for neuroprotection in preterm infants","volume":"382","author":"Juul SE","year":"2020","unstructured":"Juul SE, Comstock BA, Wadhawan R, et al.. A randomized trial of erythropoietin for neuroprotection in preterm infants. N Engl J Med. 2020, 382:233-243. 10.1056\/NEJMoa1907423","journal-title":"N Engl J Med"},{"key":"ref36","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2119660","article-title":"Trial of erythropoietin for hypoxic-ischemic encephalopathy in newborns","volume":"387","author":"Wu YW","year":"2022","unstructured":"Wu YW, Comstock BA, Gonzalez FF, et al.. Trial of erythropoietin for hypoxic-ischemic encephalopathy in newborns. N Engl J Med. 2022, 387:148-159. 10.1056\/NEJMoa2119660","journal-title":"N Engl J Med"},{"key":"ref37","doi-asserted-by":"publisher","DOI":"10.1093\/eurheartj\/ehae086","article-title":"Intravenous iron for heart failure, iron deficiency definitions, and clinical response: the IRONMAN trial","volume":"45","author":"Cleland JG","year":"2024","unstructured":"Cleland JG, Kalra PA, Pellicori P, et al.. Intravenous iron for heart failure, iron deficiency definitions, and clinical response: the IRONMAN trial. Eur Heart J. 2024, 45:1410-1426. 10.1093\/eurheartj\/ehae086","journal-title":"Eur Heart J"},{"key":"ref38","doi-asserted-by":"publisher","DOI":"10.1007\/s00277-025-06193-5","article-title":"Ravulizumab demonstrates long-term efficacy, safety and favorable patient survival in patients with paroxysmal nocturnal hemoglobinuria","volume":"104","author":"Kulasekararaj A","year":"2025","unstructured":"Kulasekararaj A, Brodsky R, Schrezenmeier H, et al.. Ravulizumab demonstrates long-term efficacy, safety and favorable patient survival in patients with paroxysmal nocturnal hemoglobinuria. Ann Hematol. 2025, 104:81-94. 10.1007\/s00277-025-06193-5","journal-title":"Ann Hematol"},{"key":"ref39","doi-asserted-by":"publisher","DOI":"10.1186\/s13045-017-0527-7","article-title":"Long-term survival in patients treated with ruxolitinib for myelofibrosis: COMFORT-I and -II pooled analyses","volume":"10","author":"Verstovsek S","year":"2017","unstructured":"Verstovsek S, Gotlib J, Mesa RA, et al.. Long-term survival in patients treated with ruxolitinib for myelofibrosis: COMFORT-I and -II pooled analyses. J Hematol Oncol. 2017, 10:156. 10.1186\/s13045-017-0527-7","journal-title":"J Hematol Oncol"},{"key":"ref40","doi-asserted-by":"publisher","DOI":"10.1182\/bloodadvances.2024015102","article-title":"Eltrombopag in combination with immunosuppressive therapy in pediatric severe aplastic anemia: phase 2 ESCALATE trial","volume":"9","author":"Shimamura A","year":"2025","unstructured":"Shimamura A, Maschan A, Bennett C, et al.. Eltrombopag in combination with immunosuppressive therapy in pediatric severe aplastic anemia: phase 2 ESCALATE trial. Blood Adv. 2025, 9:3728-3738. 10.1182\/bloodadvances.2024015102","journal-title":"Blood Adv"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/476910-blood-transfusion-practices-in-rural-hospitals-indications-challenges-and-practical-solutions","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,10]],"date-time":"2026-04-10T04:52:44Z","timestamp":1775796764000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/476910-blood-transfusion-practices-in-rural-hospitals-indications-challenges-and-practical-solutions"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,9]]},"references-count":40,"URL":"https:\/\/doi.org\/10.7759\/cureus.106752","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2026,4,9]]}}}